THRD
Third Harmonic Bio
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
THRD Profile
Third Harmonic Bio, Inc.
A clinical-stage biopharmaceutical company that develops medicine for allergy and inflammation
Pharmaceutical
04/25/2019
09/15/2022
NASDAQ Stock Exchange
53
12-31
Common stock
1700 Montgomery Street, Suite 210, San Francisco, California 94111
--
Third Harmonic Bio, Inc., was incorporated under the laws of the State of Delaware on April 25, 2019. The company is a biopharmaceutical company focused on advancing the next wave of medications for skin, respiratory, and gastrointestinal inflammatory diseases. The company is developing a next-generation, highly selective, oral KIT small molecule inhibitor, a cell surface receptor that acts as a primary regulator of mast cell function and survival.